| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Insight Molecular Diagnostics Inc. | Chief Financial Officer | Common Stock | 189,056 | $1,136,226 | $6.01 | 31 Oct 2025 | Direct |
| Insight Molecular Diagnostics Inc. | Chief Financial Officer | Restricted Stock Units | 50,000 | $232,074 | $2.05 | 31 Oct 2025 | Direct |
| Insight Molecular Diagnostics Inc. | Chief Financial Officer | Option to Purchase Common Stock | 235,000 | 28 Sep 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| OCX | Insight Molecular Diagnostics Inc. | 31 Oct 2025 | 3 | -$73,172 | 4/A | Chief Financial Officer | 13 Nov 2025, 16:34 |
| OCX | Insight Molecular Diagnostics Inc. | 28 Sep 2025 | 1 | $0 | 4 | Chief Financial Officer | 30 Sep 2025, 16:57 |
| OCX | Oncocyte Corp | 26 Mar 2025 | 1 | $0 | 4 | Chief Financial Officer | 28 Mar 2025, 16:05 |
| OCX | Oncocyte Corp | 07 Feb 2025 | 1 | +$200,000 | 4 | Chief Financial Officer | 11 Feb 2025, 19:00 |
| OCX | Oncocyte Corp | 05 Dec 2024 | 1 | +$45,800 | 4 | Chief Financial Officer | 09 Dec 2024, 08:00 |
| OCX | Oncocyte Corp | 11 Oct 2024 | 2 | $0 | 4 | Chief Financial Officer | 15 Oct 2024, 16:15 |
| OCX | Oncocyte Corp | 02 Oct 2024 | 1 | +$100,000 | 4 | Chief Financial Officer | 04 Oct 2024, 19:40 |
| OCX | Oncocyte Corp | 20 Jun 2024 | 2 | $0 | 4 | Chief Financial Officer | 24 Jun 2024, 16:49 |
| OCX | Oncocyte Corp | 17 Jun 2024 | 0 | $0 | 3 | Chief Financial Officer | 24 Jun 2024, 16:47 |